Brownfield Lab

Fans of the lung and the processes that construct and repair them.

[Brownfield Lab @BrownfieldLab]

Please check out our new publication in Nature Communications to learn about when/where AT2s emerge and how their fate plasticity is regulated! Thanks @MayoPCCM @hsphniehsctr @NatureComms @mayoclinicBMB
https://t.co/4CLRUJDR8r
https://t.co/JDTR9MYoct

[Brownfield Lab @BrownfieldLab]

🫁👩‍🔬Hot off the (pre)press! Alveolar cells flirt with fate ‘til C/EBPα lays down the law. A pulse of Dlk1 suppresses Notch to split AT1/AT2 paths—like molecular speed dating. Injury? CHOP crashes the party. https://t.co/goXnRJJZie @MayoClinic @HarvardEnvHlth

[Brownfield Lab @BrownfieldLab]

My group and I were thrilled to receive our second Notice of Award of an R01 we submitted to Dev2. We thank the study section members,@nih_nhlbi, @HarvardEnvHlth, and @MayoPCCM. We are escatic to pursue the molecular determinants of fate plasticity in the lung!

[Brownfield Lab @BrownfieldLab]

My group and I were thrilled to receive our first Notice of Award of an R01 we submitted to LIRR. We thank the study section members, @nih_nhlbi , @HarvardEnvHlth , and @MayoPCCM . We are stoked to pursue the biophysical underpinnings of stem cells in the lung!

[Stijn De Langhe @Delanghelab]

Glad to share our new paper in cell reports.
Niche-mediated repair of airways is directed in an occupant-dependent manner: Cell Reports https://t.co/R51Q9BMoLb

[Brownfield Lab @BrownfieldLab]

@CarlaKimLab @Kottond @JCI_insight @LabStripp @carogar7 Congrats! Exciting work and very useful data for optimizing AT2 expansion in culture!

[Brownfield Lab @BrownfieldLab]

Thanks for bringing attention to our work!

[MayoPCCM @MayoPCCM]

Read Dr. Brownfield's et al work on alveolar cell fate selection and lifelong maintenance of AT2 cells by FGF signaling. The work by Drs. Brownfield and Krasnow's team will help develop cell-based therapeutics to treat lung disease. @NatureComms

https://t.co/EGuBNvvDjR

[Elisabeth Bik @MicrobiomDigest]

Oh dear. I am finding new problems in a @CurrentBiology paper by the current Stanford University president, while working at Genentech (but not the corresponding author).
https://t.co/fLpmRIRcPC
https://t.co/5B3sREXwda

[MayoRegMed @MayoRegMed]

.@MayoClinic is one of the first to offer a #RegenMed Ph.D. track to train scientists and physicians to deliver health care of the future.
https://t.co/uKbAyhzERP

[MayoRegMed @MayoRegMed]

.@MayoClinc #RegenMed is training the regenerative scientists of the future to advance an emerging field focused on rebuilding and restoring health.
https://t.co/kzkv0zK6Bk

[Brownfield Lab @BrownfieldLab]

We published @NatureComms! It started @StanfordBiochem, completed @HarvardEnvHlth, and accepted now @MayoPCCM @Mayocliniclabs @MayoRegMed. Thanks @nih_nhlbi @ACSCAN! Next we translate our findings to improve regenerative medicine for the lung! #MayoREGS

https://t.co/wv6OHwX1b4

[Brownfield Lab @BrownfieldLab]

@TheLutolfLab Congrats, very cool work!